Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 2/2007

01.04.2007 | Original Paper

Prioritising drug and therapeutics committee (DTC) decisions: a national survey

verfasst von: Ee Lyn Tan, Richard O. Day, Jo-anne E. Brien

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 2/2007

Einloggen, um Zugang zu erhalten

Abstract

Objective

A national survey was conducted to explore stakeholder opinions about: (1) the domains of activity and criteria used to determine “important” decisions; (2) the “importance” of Drug and Therapeutics Committee (DTC) decisions as an appropriate approach for prioritising implementation and actions and (3) how DTC decisions could be prioritised for action.

Setting

This is a study of DTCs conducted in the Australian health care setting.

Methods

A semi-structured questionnaire was sent to Directors of Pharmacies or Chief Pharmacists in Australian hospitals. Questionnaires could be returned by email or by fax. Two weeks after initial mail-out, non-responders were followed-up. Responses were collated and analysed using descriptive statistics. Free-text responses were collated. QSR NVivo© was used as a data management tool.

Results

The response rate was 61%. All respondents indicated that “patient safety” was a domain of importance for a decision. Other domains of important DTC decisions include: “ensuring the practice of evidence based medicine within their institution” (94%), “cost” (93%), “ensure practice according to legislative requirements” (87%). Most respondents agreed that some DTC decisions were more important than others. Given constraints on time and resources, the majority agreed that DTC decisions should be prioritised for implementation, although most had no suggestions about how this could be done. Some suggested that the domains of importance could be the basis for priority assignment.

Conclusion

Currently DTC decisions and policies are implemented in an ad hoc manner. As a result implementation may be incomplete and ineffective, and may pose a risk of serious consequences in patient care. This study identifies the domains or criteria of DTC decisions so that DTCs may allocate scarce resources to the systematic implementation of important decisions.
Literatur
1.
Zurück zum Zitat Miller B, Plumridge R. Drug and therapeutics committees in Australian hospitals: an assessment of effectiveness. Aust J Hosp Pharm 1983; 13(2):61–4. Miller B, Plumridge R. Drug and therapeutics committees in Australian hospitals: an assessment of effectiveness. Aust J Hosp Pharm 1983; 13(2):61–4.
2.
Zurück zum Zitat Weekes L, Brooks C. Drug and therapeutics committees in Australia: expected and actual performance. Br J Clin Pharmacol 1996; 42(5):551–7.PubMed Weekes L, Brooks C. Drug and therapeutics committees in Australia: expected and actual performance. Br J Clin Pharmacol 1996; 42(5):551–7.PubMed
3.
Zurück zum Zitat Holloway K, Green T. Drug and therapeutics committees: a practical guide. Geneva: World Health Organisation. 2003 [Available from: mednet2.who.int/tbs/rational/s4882e.pdf]. Holloway K, Green T. Drug and therapeutics committees: a practical guide. Geneva: World Health Organisation. 2003 [Available from: mednet2.who.int/tbs/rational/s4882e.pdf].
4.
Zurück zum Zitat Heemink I, Molero-Montes M, Tabit E, et al. Review of the functioning of P&T committees in Boston-area hospitals—Part 1. NJ: Quadrant Healthcom Inc.; 1999. Heemink I, Molero-Montes M, Tabit E, et al. Review of the functioning of P&T committees in Boston-area hospitals—Part 1. NJ: Quadrant Healthcom Inc.; 1999.
5.
Zurück zum Zitat Abramowitz P. Controlling financial variables—changing prescribing patterns. Am J Hosp Pharm 1984; 41:503–15.PubMed Abramowitz P. Controlling financial variables—changing prescribing patterns. Am J Hosp Pharm 1984; 41:503–15.PubMed
6.
Zurück zum Zitat Yapp P, Steere N. The role and impact of the drug and therapeutics committee on drug utilisation in hospital. Aust J Hosp Pharm 1980; 10(4):152–3. Yapp P, Steere N. The role and impact of the drug and therapeutics committee on drug utilisation in hospital. Aust J Hosp Pharm 1980; 10(4):152–3.
7.
Zurück zum Zitat American Society of Hospital Pharmacists. ASHP statement on the pharmacy and therapeutics committees. Am J Hosp Pharm 1978; 35:813–4. American Society of Hospital Pharmacists. ASHP statement on the pharmacy and therapeutics committees. Am J Hosp Pharm 1978; 35:813–4.
8.
Zurück zum Zitat Schein E. Organizational culture and leadership. 2nd ed. San Francisco: Jossey-Bass. 1997. ISBN: 0787903620. Schein E. Organizational culture and leadership. 2nd ed. San Francisco: Jossey-Bass. 1997. ISBN: 0787903620.
9.
Zurück zum Zitat Summers K, Szeinbach S. Formularies: the role of pharmacy and therapeutics (P&T) Committees. Clin Ther 1993; 15(2):433–41.PubMed Summers K, Szeinbach S. Formularies: the role of pharmacy and therapeutics (P&T) Committees. Clin Ther 1993; 15(2):433–41.PubMed
10.
Zurück zum Zitat Wade W, Spruill WJ, Taylor AT, et al. The expanding role of pharmacy and therapeutics committees—The 1990s and beyond. Phamacoecon 1996; 10(2):123–6. Wade W, Spruill WJ, Taylor AT, et al. The expanding role of pharmacy and therapeutics committees—The 1990s and beyond. Phamacoecon 1996; 10(2):123–6.
11.
Zurück zum Zitat Tan E, Day R, Brien J. Drug and therapeutics committees—are they fulfilling their potential to improve the quality use of medicines? Int J Pharm Pract 2003; 11:175–81.CrossRef Tan E, Day R, Brien J. Drug and therapeutics committees—are they fulfilling their potential to improve the quality use of medicines? Int J Pharm Pract 2003; 11:175–81.CrossRef
12.
Zurück zum Zitat Tan E, Day R, Brien J. Stakeholder opinions on the implementation of drug and therapeutics committee decisions. J Pharm Pract Res 2004; 34:178–82. Tan E, Day R, Brien J. Stakeholder opinions on the implementation of drug and therapeutics committee decisions. J Pharm Pract Res 2004; 34:178–82.
13.
Zurück zum Zitat Tan E, Day R, Brien J. Perspectives on drug and therapeutics committee (DTC) policy implementation. Res Soc Adm Pharm 2005; 1:526–45. Tan E, Day R, Brien J. Perspectives on drug and therapeutics committee (DTC) policy implementation. Res Soc Adm Pharm 2005; 1:526–45.
14.
Zurück zum Zitat Society of Hospital Pharmacists of Australia (2004) Directory of hospital pharmacy and pharmaceutical organisations. The Society of Hospital Pharmacists of Australia, SHPA, Australia. Society of Hospital Pharmacists of Australia (2004) Directory of hospital pharmacy and pharmaceutical organisations. The Society of Hospital Pharmacists of Australia, SHPA, Australia.
15.
Zurück zum Zitat Tenni P, Hughes J. National survey of clinical pharmacy services. Aust J Hosp Pharm 1996; 26(4):416–27. Tenni P, Hughes J. National survey of clinical pharmacy services. Aust J Hosp Pharm 1996; 26(4):416–27.
16.
Zurück zum Zitat Weekes L, Day R. The application of adverse drug reaction (ADR) data to drug choice decisions made by pharmacy and therapeutics (P&T) committees: an Australian perspective. Drug Saf 1998; 18(3):153–9.PubMedCrossRef Weekes L, Day R. The application of adverse drug reaction (ADR) data to drug choice decisions made by pharmacy and therapeutics (P&T) committees: an Australian perspective. Drug Saf 1998; 18(3):153–9.PubMedCrossRef
17.
Zurück zum Zitat The University of York. Effective health care: getting evidence into practice. London: The Royal Society of Medicine Press, 1999. p. 1–16. The University of York. Effective health care: getting evidence into practice. London: The Royal Society of Medicine Press, 1999. p. 1–16.
18.
Zurück zum Zitat Davidoff F, Haynes B, Sackett D, et al. Evidence based medicine. BMJ 1995; 310:1085–6.PubMed Davidoff F, Haynes B, Sackett D, et al. Evidence based medicine. BMJ 1995; 310:1085–6.PubMed
19.
Zurück zum Zitat Commonwealth Department of Health and Aged Care. National medicines policy 2000. Canberra: Publications Production Unit (Public Affairs, Parliamentary and Access Branch); 1999. Commonwealth Department of Health and Aged Care. National medicines policy 2000. Canberra: Publications Production Unit (Public Affairs, Parliamentary and Access Branch); 1999.
20.
Zurück zum Zitat Roughead E, Semple S. Second national report on patient safety: improving medication safety. Australian Council for Safety and Quality in Healthcare; 2002. Roughead E, Semple S. Second national report on patient safety: improving medication safety. Australian Council for Safety and Quality in Healthcare; 2002.
21.
Zurück zum Zitat Weekes L. Organisational structures to promote quality use of medicines, in school of community medicine, faculty of medicine. PhD thesis, Sydney: University of New South Wales; 2000. p. 354. Weekes L. Organisational structures to promote quality use of medicines, in school of community medicine, faculty of medicine. PhD thesis, Sydney: University of New South Wales; 2000. p. 354.
Metadaten
Titel
Prioritising drug and therapeutics committee (DTC) decisions: a national survey
verfasst von
Ee Lyn Tan
Richard O. Day
Jo-anne E. Brien
Publikationsdatum
01.04.2007
Verlag
Kluwer Academic Publishers
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 2/2007
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-006-9074-y

Weitere Artikel der Ausgabe 2/2007

International Journal of Clinical Pharmacy 2/2007 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.